WO2001064713A3 - Mammalian interleukin-10 (il-10) receptor variants - Google Patents
Mammalian interleukin-10 (il-10) receptor variants Download PDFInfo
- Publication number
- WO2001064713A3 WO2001064713A3 PCT/EP2001/002296 EP0102296W WO0164713A3 WO 2001064713 A3 WO2001064713 A3 WO 2001064713A3 EP 0102296 W EP0102296 W EP 0102296W WO 0164713 A3 WO0164713 A3 WO 0164713A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- receptor variants
- mammalian interleukin
- therapeutic
- diagnostic
- reagents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001256174A AU2001256174A1 (en) | 2000-03-01 | 2001-03-01 | Mammalian interleukin-10 (il-10) receptor variants |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18612500P | 2000-03-01 | 2000-03-01 | |
US60/186,125 | 2000-03-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001064713A2 WO2001064713A2 (en) | 2001-09-07 |
WO2001064713A3 true WO2001064713A3 (en) | 2002-06-27 |
Family
ID=22683741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/002296 WO2001064713A2 (en) | 2000-03-01 | 2001-03-01 | Mammalian interleukin-10 (il-10) receptor variants |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001256174A1 (en) |
WO (1) | WO2001064713A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8945543B2 (en) | 2005-06-10 | 2015-02-03 | Chugai Seiyaku Kabushiki Kaisha | Stabilizer for protein preparation comprising meglumine and use thereof |
US9241994B2 (en) | 2005-06-10 | 2016-01-26 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical compositions containing sc(Fv)2 |
US9493569B2 (en) | 2005-03-31 | 2016-11-15 | Chugai Seiyaku Kabushiki Kaisha | Structural isomers of sc(Fv)2 |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7696325B2 (en) | 1999-03-10 | 2010-04-13 | Chugai Seiyaku Kabushiki Kaisha | Polypeptide inducing apoptosis |
CN1308448C (en) | 2000-10-20 | 2007-04-04 | 中外制药株式会社 | Degraded TPO agonist antibody |
JP2004279086A (en) | 2003-03-13 | 2004-10-07 | Konica Minolta Holdings Inc | Radiation image conversion panel and method for manufacturing it |
EP1616880A4 (en) * | 2003-03-13 | 2006-07-26 | Chugai Pharmaceutical Co Ltd | Ligand having agonistic activity to mutated receptor |
ES2592271T3 (en) | 2005-03-31 | 2016-11-29 | Chugai Seiyaku Kabushiki Kaisha | Polypeptide production methods by regulating the association of polypeptides |
US9670269B2 (en) | 2006-03-31 | 2017-06-06 | Chugai Seiyaku Kabushiki Kaisha | Methods of modifying antibodies for purification of bispecific antibodies |
US20160090637A1 (en) * | 2013-05-14 | 2016-03-31 | Wei Chen | Pharmacogenomic Biomarkers for B Cell Malignancies and Methods of Use Thereof |
AU2014325063B2 (en) | 2013-09-27 | 2019-10-31 | Chugai Seiyaku Kabushiki Kaisha | Method for producing polypeptide heteromultimer |
KR20180091918A (en) | 2015-12-28 | 2018-08-16 | 추가이 세이야쿠 가부시키가이샤 | A method for efficiently purifying the Fc region-containing polypeptide |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5716804A (en) * | 1995-04-19 | 1998-02-10 | Schering Corporation | Mammalian interleukin-10 (IL-10) super-activating receptors; and variants |
US5863796A (en) * | 1992-12-10 | 1999-01-26 | Schering Corporation | Antibodies which specifically bind mammalian receptors for interleukin-10 (IL-10) |
-
2001
- 2001-03-01 WO PCT/EP2001/002296 patent/WO2001064713A2/en active Application Filing
- 2001-03-01 AU AU2001256174A patent/AU2001256174A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5863796A (en) * | 1992-12-10 | 1999-01-26 | Schering Corporation | Antibodies which specifically bind mammalian receptors for interleukin-10 (IL-10) |
US5985828A (en) * | 1992-12-10 | 1999-11-16 | Schering Corporation | Mammalian receptors for interleukin-10 (IL-10) |
US5716804A (en) * | 1995-04-19 | 1998-02-10 | Schering Corporation | Mammalian interleukin-10 (IL-10) super-activating receptors; and variants |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9493569B2 (en) | 2005-03-31 | 2016-11-15 | Chugai Seiyaku Kabushiki Kaisha | Structural isomers of sc(Fv)2 |
US8945543B2 (en) | 2005-06-10 | 2015-02-03 | Chugai Seiyaku Kabushiki Kaisha | Stabilizer for protein preparation comprising meglumine and use thereof |
US9241994B2 (en) | 2005-06-10 | 2016-01-26 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical compositions containing sc(Fv)2 |
Also Published As
Publication number | Publication date |
---|---|
WO2001064713A2 (en) | 2001-09-07 |
AU2001256174A1 (en) | 2001-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1008830A1 (en) | Mammalian receptors for interleukin | |
WO2001085790A3 (en) | Mammalian cytokine receptor subunit proteins, related reagents and methods | |
MY157028A (en) | Mammalian cytokine, related reagents | |
WO2001064713A3 (en) | Mammalian interleukin-10 (il-10) receptor variants | |
WO2001090358A3 (en) | Mammalian receptor proteins; related reagents and methods | |
WO2000042188A3 (en) | Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses | |
EP2292760A3 (en) | Mammalian cytokines, receptors, related reagents and methods | |
EP1433792A8 (en) | Human receptor proteins, related reagents and methods | |
WO2001036467A3 (en) | Mammalian receptor proteins; related reagents and methods | |
WO1998001557A3 (en) | Mammalian chemokine reagents | |
WO1999046379A3 (en) | Human receptor proteins; related reagents and methods | |
AU5305300A (en) | Mammalian receptor proteins; related reagents and methods | |
WO1998032858A3 (en) | Mammalian chemokines; receptors; reagents; uses | |
WO2003020005A3 (en) | Lp mammalian proteins; related reagents | |
WO1998023750A3 (en) | Mammalian chemokines | |
WO1998031810A3 (en) | Mammalian chemokines; receptors; reagents; uses | |
WO2002068596A3 (en) | Mammalian cytokines; related reagents | |
WO2002074906A3 (en) | Lp mammalian proteins; related reagents | |
WO1992016623A3 (en) | Receptors for bombesin-like peptides | |
WO2005065711A3 (en) | Mammalian receptor proteins; related reagents and methods | |
WO2003012120A3 (en) | Lp354 mammalian secreted protein | |
WO2002063009A3 (en) | Lp mammalian proteins; related reagents | |
EP0854186A3 (en) | Staphylococcus aureus cell division gene DivIB | |
WO1998041538A3 (en) | Novel human cytokine/steroid receptor protein | |
WO1999019480A3 (en) | Human receptor proteins; related reagents and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |